Definitive Contract HHSN268201600014C
Award Date
3/1/16
Potential Completion Date
2/7/19
Potential Value
$4.3M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,327,796.91, was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to SRI International, a non-profit research and development institute, for biomedical research and development (R&D) in the basic research domain. The contract does not have a set-aside designation. SRI International, as the prime contractor, will perform the...
This is a $4,228,000.27 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (a component of the U.S. Department of Health and Human Services) to the non-profit research institute SRI International. The contract is for investigational new toxicology studies for drugs to treat Alzheimer's disease and other aging-related diseases. The contract does not have a small business set-aside designation. SRI International is an experienced federal contractor and grantee, frequently...
This federal contract award was issued by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse to SRI International, a non-profit research and development institute, for the Pharmacology and Toxicology for Therapeutics Program (PTTP). The $2,363,694.00 cost-plus-fixed-fee contract is a delivery order under a larger IDIQ (Indefinite Delivery/Indefinite Quantity) vehicle. The contract does not have a set-aside designation. SRI International...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) to SRI International, a nonprofit research and development institute. The purpose of the contract is to conduct purpose interaction safety studies in rats and dogs, with a period of performance from March 25, 2020 to March 24, 2021. The total potential value of the contract is $1,206,338.00. The contract is part of...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Cost Plus Fixed Fee delivery order contract to SRI International, a non-profit research and development institute. The $1,256,044.00 contract is for GLP (Good Laboratory Practice) interaction safety studies in rats and dogs, under an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. The contract is not set aside for any specific business type. SRI International...
This is a $67,787,765.29 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to SRI International, a non-profit research and development institute, for preclinical toxicology and pharmacology of drugs. The contract supports biomedical research and drug development services for the NCI. SRI International has multiple indefinite delivery vehicles (IDVs) with federal agencies like the Department of Defense, NASA, and the National Institutes of Health that enable efficient...
This is a $3,266,358.78 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services (HHS), to SRI International, a large non-profit research and development organization. The contract supports the ARRA (American Recovery and Reinvestment Act) biological testing facility for NICHD/CPR. There is no small business set-aside. SRI International has expertise across a wide range of...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services, to SRI International, a non-profit research and development institute. The $852,628.88 contract supports biological testing facility services and is funded through the American Recovery and Reinvestment Act (ARRA). The work appears to involve preclinical research and development related to areas such as...
This is a $748,053.07 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Sri International, a non-profit research and development institute, to conduct medical and biomedical applied research and exploratory development. This work falls under the agency's Biological Testing Facility major program. The contract does not have a...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime...